2-Part NIH Grant Writing Series: Research Strategy, Aims and Narrative
You may not realize it, but approximately 90% of your NIH grant application's success can be attributed to how well you grab the interest of your peer reviewers.
That's why grant writing experts Dorothy Lewis, PhD and Christopher Dant, PhD have put together two online training sessions included in the 2-Part NIH Grant Writing Tactics Series, that will help you build a winning NIH proposal and get the funding you need.
Order this 2-part series within the next 2 days, and you'll save an additional $100 off the total cost. Or, if you prefer, you can order each session individually without the discount. ORDER NOW!
You take no risk whatsoever. If you find this essential session doesn't meet your expectations or you are not satisfied for any reason, simply let us know.
NIH reviewers want more from your Research Strategy than to just know about your experiments. They want to understand you’ll solve the problems you’ve identified.
With NIH funding opportunities decreasing, and competition rising, mastering what reviewers want from your Research Strategy can push your grant application to the top of the funding pile. To successfully meet the requirements of the Research Strategy components of an NIH grant you must provide strong, independent Specific Aims, a solid background with clear scientific premise, how you will overcome potential challenges and the impact of what your research will accomplish.
You can learn how to craft your Significance, Innovation and Approach sections while cohesively integrating your Specific Aims into a winning Research Strategy Plan by joining grant writing expert, Dr. Dorothy Lewis PhD, during her 90-minute training session “NIH Research Strategy: Actionable Steps to Get Your Application Funded,”. You’ll walk away from this valuable training with actionable tactics to help you tackle the Specific Aims, Significance, Innovation and Approach sections of your Research Plan to improve your funding success.
The Research Strategy section of your application is crucial to your proposal success. New and veteran investigators alike can make common, preventable - but nevertheless serious - mistakes that lead to funding rejection. Here are just a few of the step-by-step Research Strategy preparation strategies you’ll receive by watching this 90-minute training:
You may not realize it, but approximately 90% of your NIH grant application’s success can be attributed to how well you grab the interest of your peer reviewers.
Grant writing is essentially storytelling, and your Specific Aims page and Project Narrative are center stage. They can make or break peer reviewer interest and enthusiasm, and often immediately sink your grant before it is read in detail killing your chances of getting funded right out of the gate.
Despite the overwhelming importance of these sections, knowing how to execute them to attract the attention of your reviewer is not straightforward. The good news is, that with understanding of what peer reviewers expect to see, you can get your grant noticed and edge ahead of the competition. This is where medical researcher and educator, Christopher Dant, PhD, can help.
Construct your Specific Aims Page to incorporate exactly what NIH reviewers expects. During his 90-minute online training workshop, you’ll learn how to make your grant application stand out above the fierce NIH competition. Ultimately, the goal of this training is to improve your chances of getting funded. Here are just a few of the proven tactics you’ll be able to utilize after watching this expert-led online session:
Dr. Lewis is a Professor of Internal Medicine, Infectious Diseases at the McGovern Medical School at the University of Texas Health Science center in Houston. Dr. Lewis received her PhD in Microbiology in 1978 from the University of Arizona. She did an NIH supported postdoctoral fellowship on the genetics of autoimmune disease and then became a faculty member at Baylor College of Medicine.
Dr. Lewis is a cellular immunologist who has studied HIV pathogenesis for over 35 years. She was one of the first to identify CD8 dysfunction and cell death in HIV infected patients, one of the first to realize that much more HIV was being produced in vivo and has recently focused on understanding mechanisms responsible for metabolic dysfunction in HIV infected patients. This novel work shows that HIV infected immune cells are in diverse adipose tissues, the HIV is infectious and that adipose is likely a sanctuary for HIV that will be difficult to clear by CD8 responses or via ART. She has had continual NIH funding since 1985. Dr. Lewis has served on many NIH study sections and was Chair of the AIDS Immunopathogenesis study section from 2009-2011. She also served on the NIAID council from 2002-2006. She was a member of the Training and Workforce Diversity review panel from 2012-16. She developed a mentoring program for graduate students, postdoctoral fellows and young faculty members. She teaches grant writing to students at Baylor College of Medicine and at the Graduate School for Biomedical Sciences. She is the author of more than 190 papers and several book chapters.
He worked as a senior writer and managed publications at Stanford’s Medical School and established and built the Clinical Publications Division at Genentech in California. Until recently, Dr. Dant served on the faculty at Dartmouth Medical School and Norris Cotton Cancer Center to deliver lectures on NIH grant writing and manuscript writing. He lectures widely in academic and biopharmaceutical settings on manuscript writing, NIH career and research grants, and basic scientific writing skills for scientists and his business, MEDCOM Consulting, serves academic clients to review and write research and training grants for the NIH.Christopher Dant is a PhD-trained medical researcher and educator with over 40 years’ experience in government, academic, and biopharmaceutical settings. His PhD training was in immunology and cellular biology and he previously conducted research for several medical institutions in the United States.